Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

NCT07410494 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Breast Cancer
Non-Small Cell Lung Cancer (NSCLC)
Colorectal Cancer (Locally Advanced or Metastatic)
Prostate Cancer - Recurrent
Pancreatic Ductal Adenocarcinoma (PDAC)
Ovarian Cancer
Glioblastoma
Melanoma (Skin Cancer)
Acute Myeloid Leukemia (AML)
Non Hodgkin Lymphoma
Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
Liver Cancer

Interventions

BIOLOGICAL: EB-SELECT Single-Target CAR-NK Cells
BIOLOGICAL: Dual-Target Antigen-Selected CAR-NK

Sponsor

Essen Biotech